Serialization in the Production of Medicinal Products
Syntacoll
Syntacoll Serializes Medication to Protect against Falsified Medicines along the Legal Supply Chain
All over the world, more and more countries are launching initiatives and statutory regulations with the aim of preventing falsified medicine from entering the legal supply chain. These involve the verification of prescription drugs at the packaging level as well as making it detectable that they have not been tampered with.
Customer Benefits
About Syntacoll
Syntacoll specializes in the development and manufacturing of innovative collagen products for medical and pharmaceutical applications. One of its core technologies is tissue engineering: the development of rapid, long-lasting equivalents for healing acute and chronic wounds. The medical products are produced in the company’s own production facilities. In the development process, the company cooperates with German and international universities, medical centers, and institutes. Syntacoll is a subsidiary of Innocoll Pharmaceuticals (Ireland).